Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Nasal & Pulmonary Drug Development
Novo Nordisk 20 March 2024, 11:21
Carterra – 24th March 2025

Laetus


Laetus is the world-leading supplier of innovative and value-adding quality & security inspection systems and complete Track & Trace solutions for the Pharmaceutical, Medical, Cosmetics and FMCG industries. Our goal is to secure the authenticity and quality of products, thus ensuring the health of patients and consumers.
With more than 43 years of market experience and our global network of sales, service and project management staff, we help our customers to maintain the highest levels of product quality and production efficiency.
Many of our product brands for vision inspection such as ARGUS, INSPECT and POLYPHEM have become market standards in code reading, quality assurance and fill inspection. More than 20.000 systems sold all over the world include more than 42.000 Laetus cameras and sensors.
We have branches in USA, Mexico, Brazil, China, UK and Ireland, Italy, Spain, Poland and France and more than 50 sales representatives worldwide.
Technological innovation and a strong commitment to our customers and partners have always been our key focus. Therefore, our R&D is staffed with more than 60 employees.
Our Track & Track Academy is more than just a training centre. Laetus has created an extensive pool of expertise on the topic of Track & Trace. A modular training concept with a fully equipped showroom and an individually designed training programme underscore the uniqueness of the Academy.
Since December 2015, Laetus is a member of the Danaher group. Laetus is a part of the Product Identification Platform with ALLTEC/FOBA, Esko, Linx, Pantone, Videojet and X-Rite.
Further information about the services offered by Laetus:  http://www.laetus.com

Scott Pharma – 25.03.2025
SMI – 24/03/2025
Chemspec Europe – 27.02.2025
PHARMAP: Mon 14 October 2024, 10.36
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
L.B. Bohle – 08.04.2025